| scholarly article | Q13442814 |
| P50 | author | Dean Burkin | Q56759871 |
| Ryan D. Wuebbles | Q64764218 | ||
| P2093 | author name string | Jachinta E Rooney | |
| Erika T Allred | |||
| Jinger A Doe | |||
| Margaret Elorza | |||
| P2860 | cites work | Mutations in the laminin alpha 2-chain gene (LAMA2) cause merosin-deficient congenital muscular dystrophy | Q24308817 |
| Mutations in the integrin alpha7 gene cause congenital myopathy | Q24317420 | ||
| Absence of integrin alpha 7 causes a novel form of muscular dystrophy | Q24323372 | ||
| The expanding phenotype of laminin alpha2 chain (merosin) abnormalities: case series and review | Q24680748 | ||
| Activation of the lama2 gene in muscle regeneration: abortive regeneration in laminin alpha2-deficiency | Q28141536 | ||
| Laminin and alpha7beta1 integrin regulate agrin-induced clustering of acetylcholine receptors | Q28141768 | ||
| Merosin and congenital muscular dystrophy | Q28145060 | ||
| Integrins (alpha7beta1) in muscle function and survival. Disrupted expression in merosin-deficient congenital muscular dystrophy | Q28249995 | ||
| Expression of alpha 7 integrin cytoplasmic domains during skeletal muscle development: alternate forms, conformational change, and homologies with serine/threonine kinases and tyrosine phosphatases | Q28250493 | ||
| Alternative extracellular and cytoplasmic domains of the integrin alpha 7 subunit are differentially expressed during development | Q28257104 | ||
| Altered expression of the alpha7beta1 integrin in human and murine muscular dystrophies | Q28258806 | ||
| Omigapil ameliorates the pathology of muscle dystrophy caused by laminin-alpha2 deficiency | Q28258826 | ||
| A new isoform of the laminin receptor integrin alpha 7 beta 1 is developmentally regulated in skeletal muscle | Q28261983 | ||
| Synaptic integrins in developing, adult, and mutant muscle: selective association of alpha1, alpha7A, and alpha7B integrins with the neuromuscular junction | Q28278128 | ||
| Role for the alpha7beta1 integrin in vascular development and integrity | Q28504523 | ||
| Distribution and function of laminins in the neuromuscular system of developing, adult, and mutant mice | Q28593330 | ||
| Laminin alpha1 chain mediated reduction of laminin alpha2 chain deficient muscular dystrophy involves integrin alpha7beta1 and dystroglycan | Q33234933 | ||
| Role of matrix metalloproteinases in skeletal muscle: migration, differentiation, regeneration and fibrosis | Q33575969 | ||
| The alpha7beta1 integrin in muscle development and disease | Q33592124 | ||
| Refinement of the laminin alpha2 chain locus to human chromosome 6q2 in severe and mild merosin deficient congenital muscular dystrophy | Q33678375 | ||
| Molecular basis of muscular dystrophies. | Q34044147 | ||
| Galectin-3: an open-ended story | Q34494555 | ||
| Laminin isoforms in tumor invasion, angiogenesis and metastasis | Q34706652 | ||
| Transgenic expression of {alpha}7{beta}1 integrin maintains muscle integrity, increases regenerative capacity, promotes hypertrophy, and reduces cardiomyopathy in dystrophic mice | Q35083511 | ||
| The congenital muscular dystrophies in 2004: a century of exciting progress | Q35879886 | ||
| Overexpression of the cytotoxic T cell (CT) carbohydrate inhibits muscular dystrophy in the dyW mouse model of congenital muscular dystrophy 1A. | Q35928246 | ||
| A functional role for specific spliced variants of the alpha7beta1 integrin in acetylcholine receptor clustering | Q36255897 | ||
| Laminin polymerization induces a receptor-cytoskeleton network | Q36342173 | ||
| Enhanced expression of the alpha 7 beta 1 integrin reduces muscular dystrophy and restores viability in dystrophic mice | Q36381102 | ||
| The congenital muscular dystrophies: recent advances and molecular insights | Q36681282 | ||
| Exercise promotes alpha7 integrin gene transcription and protection of skeletal muscle | Q36977244 | ||
| Laminin-111 restores regenerative capacity in a mouse model for alpha7 integrin congenital myopathy | Q37073808 | ||
| Pathology is alleviated by doxycycline in a laminin-alpha2-null model of congenital muscular dystrophy | Q37091285 | ||
| Laminin-111 protein therapy prevents muscle disease in the mdx mouse model for Duchenne muscular dystrophy | Q37194805 | ||
| Merosin-deficient congenital muscular dystrophy. Partial genetic correction in two mouse models | Q37384623 | ||
| Inhibition of apoptosis improves outcome in a model of congenital muscular dystrophy | Q37625936 | ||
| Expression and distribution of laminin alpha1 and alpha2 chains in embryonic and adult mouse tissues: an immunochemical approach | Q40736493 | ||
| A synaptic localization domain in the synaptic cleft protein laminin beta 2 (s-laminin) | Q41323947 | ||
| Selective modulation of the interaction of alpha 7 beta 1 integrin with fibronectin and laminin by L-14 lectin during skeletal muscle differentiation. | Q41498859 | ||
| Both laminin and Schwann cell dystroglycan are necessary for proper clustering of sodium channels at nodes of Ranvier. | Q41866964 | ||
| Overexpression of mini-agrin in skeletal muscle increases muscle integrity and regenerative capacity in laminin-alpha2-deficient mice. | Q42478963 | ||
| Feeding problems in merosin deficient congenital muscular dystrophy | Q42789487 | ||
| Galectin-3 mediates the endocytosis of beta-1 integrins by breast carcinoma cells | Q43816780 | ||
| Alternative splice variants of alpha 7 beta 1 integrin selectively recognize different laminin isoforms. | Q43823933 | ||
| Defective integrin switch and matrix composition at alpha 7-deficient myotendinous junctions precede the onset of muscular dystrophy in mice. | Q44316959 | ||
| Laminin alpha1 chain reduces muscular dystrophy in laminin alpha2 chain deficient mice | Q45876189 | ||
| Merosin-deficient congenital muscular dystrophy: the spectrum of brain involvement on magnetic resonance imaging | Q48224297 | ||
| Expression of laminin alpha1, alpha2, alpha4, and alpha5 chains, fibronectin, and tenascin-C in skeletal muscle of dystrophic 129ReJ dy/dy mice | Q48309316 | ||
| Laminin α2 deficiency and muscular dystrophy; genotype-phenotype correlation in mutant mice | Q58108925 | ||
| Congenital muscular dystrophy with primary laminin alpha2 (merosin) deficiency presenting as inflammatory myopathy | Q71864959 | ||
| Diagnosis and etiology of congenital muscular dystrophy | Q80412916 | ||
| P433 | issue | Pt 13 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pathology | Q7208 |
| congenital muscular dystrophy | Q1321884 | ||
| congenital disorder | Q727096 | ||
| P304 | page(s) | 2287-2297 | |
| P577 | publication date | 2011-06-07 | |
| P1433 | published in | Journal of Cell Science | Q1524177 |
| P1476 | title | Transgenic overexpression of the α7 integrin reduces muscle pathology and improves viability in the dy(W) mouse model of merosin-deficient congenital muscular dystrophy type 1A. | |
| P478 | volume | 124 |
| Q95840621 | A Family of Laminin α2 Chain-Deficient Mouse Mutants: Advancing the Research on LAMA2-CMD |
| Q27322025 | A splice site mutation in laminin-α2 results in a severe muscular dystrophy and growth abnormalities in zebrafish |
| Q28283362 | AAV-mediated overexpression of human α7 integrin leads to histological and functional improvement in dystrophic mice |
| Q37944530 | Cell-matrix interactions in muscle disease |
| Q91906240 | Current understanding and treatment of cardiac and skeletal muscle pathology in laminin-α2 chain-deficient congenital muscular dystrophy |
| Q40556372 | Deletion of integrin α7 subunit does not aggravate the phenotype of laminin α2 chain-deficient mice |
| Q89624987 | Distinct cachexia profiles in response to human pancreatic tumours in mouse limb and respiratory muscle |
| Q47337769 | Genetic modifiers of Duchenne and facioscapulohumeral muscular dystrophies |
| Q36608879 | Genetic overexpression of Serpina3n attenuates muscular dystrophy in mice |
| Q38882098 | Impaired fetal muscle development and JAK-STAT activation mark disease onset and progression in a mouse model for merosin-deficient congenital muscular dystrophy |
| Q33787898 | Improving Reproducibility of Phenotypic Assessments in the DyW Mouse Model of Laminin-α2 Related Congenital Muscular Dystrophy |
| Q89963755 | Laminin and Integrin in LAMA2-Related Congenital Muscular Dystrophy: From Disease to Therapeutics |
| Q27318580 | Laminin regulates PDGFRβ(+) cell stemness and muscle development. |
| Q28087548 | Laminin therapy for the promotion of muscle regeneration |
| Q41881081 | Laminin-111 improves muscle repair in a mouse model of merosin-deficient congenital muscular dystrophy |
| Q35952091 | Laminin-111 protein therapy reduces muscle pathology and improves viability of a mouse model of merosin-deficient congenital muscular dystrophy |
| Q37137768 | Levels of α7 integrin and laminin-α2 are increased following prednisone treatment in the mdx mouse and GRMD dog models of Duchenne muscular dystrophy |
| Q47164258 | Linker proteins restore basement membrane and correct LAMA2-related muscular dystrophy in mice. |
| Q45016329 | Mesothelioma cells breaking bad: loss of integrin α7 promotes cell motility and poor clinical outcomes in patients |
| Q31105806 | NAD+ biosynthesis ameliorates a zebrafish model of muscular dystrophy |
| Q30841381 | Potent pro-inflammatory and pro-fibrotic molecules, osteopontin and galectin-3, are not major disease modulators of laminin α2 chain-deficient muscular dystrophy |
| Q35201194 | Quantitative proteomic analysis reveals metabolic alterations, calcium dysregulation, and increased expression of extracellular matrix proteins in laminin α2 chain-deficient muscle |
| Q92487776 | Restoring the regenerative balance in neuromuscular disorders: satellite cell activation as therapeutic target in Pompe disease |
Search more.